Curis reported $-16109000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amgen AMGN:US $ 2727M 56M
Bristol Myers Squibb BMY:US $ 5386M 595M
Chimerix CMRX:US $ -24.77M 14.73M
Curis CRIS:US $ -16.11M 2.49M
Epizyme EPZM:US $ -55.47M 4.84M
Exelixis EXEL:US $ 85.23M 32.79M
Merk MRK:US $ 6309M 1525M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Sanofi SAN:FP € 2965M 804M
Takeda 4502:JP Y -54047M 126240M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
Verastem VSTM:US $ -16.96M 0.48M
Xoma XOMA:US $ -2.28M 32.22M
YTE INCY:US $ 172.84M 1.75M
Ziopharm Oncology ZIOP:US $ -9.79M 2M